HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chantal reports third quarter sales of $2 mil. on cash basis reporting.

This article was originally published in The Rose Sheet

Executive Summary

CHANTAL PHARMACEUTICAL THIRD QUARTER SALES OF $2 MIL. for the period ended March 31 are reported by Chantal in a 10-Q filed May 21. Sales, reported on a cash basis, are 28.1% below sales for the comparable period in 1995. The company recorded a $3.4 mil. net loss for the quarter versus net income of $408,752 in the prior-year period.
UsernamePublicRestriction

Register

RS002835

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel